Ontology highlight
ABSTRACT:
SUBMITTER: Gil S
PROVIDER: S-EPMC7111837 | biostudies-literature | 2014 Feb
REPOSITORIES: biostudies-literature
Research in veterinary science 20131125 1
Recombinant-Feline Interferon-Omega (rFeIFN-ω) is an immune-modulator licensed for use subcutaneously in Feline Immunodeficiency virus (FIV) therapy. Despite oral protocols have been suggested, little is known about such use in FIV-infected cats. This study aimed to evaluate the clinical improvement, laboratory findings, concurrent viral excretion and acute phase proteins (APPs) in naturally FIV-infected cats under oral rFeIFN-ω therapy (0.1 MU/cat rFeIFN-ω PO, SID, 90 days). 11 FIV-positive cat ...[more]